Harrow
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1998-01-01
- Employees
- 315
- Market Cap
- -
- Website
- http://www.harrow.com
- Introduction
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
The Effects of Low Viscosity Chloroprocaine Ophthalmic Gel 3% on the Bactericidal Action of Povidone-Iodine
Phase 4
Recruiting
- Conditions
- AntisepticAnesthesia, Local
- Interventions
- First Posted Date
- 2023-07-06
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Harrow Inc
- Target Recruit Count
- 60
- Registration Number
- NCT05934253
- Locations
- 🇺🇸
Brandon Eye Associates, Brandon, Florida, United States